Literature DB >> 4055044

The influence of third-generation cephalosporins on the aerobic intestinal flora.

J P Guggenbichler, J Kofler, F Allerberger.   

Abstract

The influence of three third-generation cephalosporins with varying degrees of biliary excretion on the aerobic flora was investigated. The faecal flora prior to therapy with one of these substances consisted mainly of anaerobic bacilli. Escherichia coli was present in concentrations of 10(9) organisms/g stool. Candida albicans and enterococci were observed in concentrations of 10(5) - 10(6) organisms/g stool. Within 24 hours after the administration of ceftriaxone and cefoperazone, the gram-negative aerobic flora was completely eradicated. C. albicans and enterococci increased to 10(9) organisms/g stool. Between the third and tenth days (mean 6.7 days) of therapy Pseudomonas aeruginosa, Enterobacter and Citrobacter in this order of frequency reappeared in the faecal flora with complete resistance to all betalactam antibiotics. C. albicans and enterococci decreased to 10(7) organisms/g stool. The anaerobic flora was largely unaltered. In contrast, cefotaxime had only a moderate influence on the aerobic faecal flora. Concentrations of gram-negative organisms decreased to 5 X 10(7) organisms/g stool during the first five days of therapy; the concomitant increase in C. albicans and enterococci was approximately 1 log 10. No alterations in the susceptibility pattern were observed. We would like to emphasize that substantial alterations of the faecal flora and the susceptibility pattern of antibiotics may accompany the use of antimicrobial agents, particularly those with a high degree of biliary elimination.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4055044     DOI: 10.1007/BF01644235

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  8 in total

1.  Colonization resistance of the digestive tract of mice during systemic antibiotic treatment.

Authors:  D van der Waaij; J M Berghuis; J E Lekkerkerk
Journal:  J Hyg (Lond)       Date:  1972-12

2.  The effect of antimicrobial agents on human faecal flora: studies with cephalexin, cyclacillin and clindamycin.

Authors:  V L Sutter; S M Finegold
Journal:  Soc Appl Bacteriol Symp Ser       Date:  1974

3.  Interaction of antimicrobial therapy and intestinal flora.

Authors:  S M Finegold
Journal:  Am J Clin Nutr       Date:  1970-11       Impact factor: 7.045

4.  Enteric pathogen--normal flora interactions.

Authors:  D J Hentges
Journal:  Am J Clin Nutr       Date:  1970-11       Impact factor: 7.045

5.  Comparative in vitro activity of ceftriaxone against anaerobic bacteria.

Authors:  R D Rolfe; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1982-08       Impact factor: 5.191

6.  Origin of infection in acute nonlymphocytic leukemia. Significance of hospital acquisition of potential pathogens.

Authors:  S C Schimpff; V M Young; W H Greene; G D Vermeulen; M R Moody; P H Wiernik
Journal:  Ann Intern Med       Date:  1972-11       Impact factor: 25.391

7.  Impact of cefoperazone therapy on fecal flora.

Authors:  M E Mulligan; D M Citron; B T McNamara; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1982-08       Impact factor: 5.191

8.  Cefoperazone concentrations in bile and gall bladder wall after intravenous administration.

Authors:  T Nakamura; I Hashimoto; Y Sawada; J Mikami; E Bekki; S Hirasawa; H Abe; Y Watanabe
Journal:  Antimicrob Agents Chemother       Date:  1980-12       Impact factor: 5.191

  8 in total
  13 in total

1.  Association between vancomycin-resistant Enterococci bacteremia and ceftriaxone usage.

Authors:  James A McKinnell; Danielle F Kunz; Eric Chamot; Mukesh Patel; Rhett M Shirley; Stephen A Moser; John W Baddley; Peter G Pappas; Loren G Miller
Journal:  Infect Control Hosp Epidemiol       Date:  2012-05-14       Impact factor: 3.254

2.  Acute necrotizing cholecystitis: a rare complication of ceftriaxone-associated pseudolithiasis.

Authors:  Sendia Kim; Kathleen M Gura; Mark Puder
Journal:  Pediatr Surg Int       Date:  2006-02-17       Impact factor: 1.827

3.  The effect of selective decontamination of the digestive tract with the addition of systemic cefotaxime on the aerobic faecal flora of mice.

Authors:  A B Speekenbrink; S R Alcock; J Forrester; D M Parrott
Journal:  Epidemiol Infect       Date:  1987-06       Impact factor: 2.451

4.  A hospital-wide intervention replacing ceftriaxone with cefotaxime to reduce rate of healthcare-associated infections caused by extended-spectrum β-lactamase-producing Enterobacteriaceae in the intensive care unit.

Authors:  Boun Kim Tan; Emmanuel Vivier; Karim Ait Bouziad; Jean-Ralph Zahar; Christian Pommier; Laurence Parmeland; Caroline Pariset; Pauline Misslin; Catherine Haond; Philippe Poirié; Laura Temime; Mounia N Hocine
Journal:  Intensive Care Med       Date:  2018-02-02       Impact factor: 17.440

5.  The in vitro inactivation of thirteen beta-lactam antibiotics by other mechanisms than adsorption to faecal substance.

Authors:  H de Vries-Hospers; G Jansen; R Tonk; D Oenema; D van der Waaij
Journal:  Infection       Date:  1993 Mar-Apr       Impact factor: 3.553

6.  Faecal candida and diarrhoea.

Authors:  D Forbes; L Ee; P Camer-Pesci; P B Ward
Journal:  Arch Dis Child       Date:  2001-04       Impact factor: 3.791

7.  MiniBioReactor Array (MBRA) in vitro gut model: a reliable system to study microbiota-dependent response to antibiotic treatment.

Authors:  C A Hobson; L Vigue; S Naimi; B Chassaing; M Magnan; S Bonacorsi; B Gachet; I El Meouche; A Birgy; O Tenaillon
Journal:  JAC Antimicrob Resist       Date:  2022-07-05

8.  Impact of digestive and oropharyngeal decontamination on the intestinal microbiota in ICU patients.

Authors:  Robin F Benus; Hermie J Harmsen; Gjalt W Welling; Rob Spanjersberg; Jan G Zijlstra; John E Degener; Tjip S van der Werf
Journal:  Intensive Care Med       Date:  2010-03-16       Impact factor: 17.440

Review 9.  Adverse effects of newer cephalosporins. An update.

Authors:  J W Thompson; R F Jacobs
Journal:  Drug Saf       Date:  1993-08       Impact factor: 5.606

10.  Investigation of the biliary clearances of cefotaxime and desacetylcefotaxime by an original procedure in cholecystectomised patients.

Authors:  F Jehl; J D Peter; A Picard; J P Dupeyron; J Marescaux; A Sibilly; H Monteil
Journal:  Infection       Date:  1987 Nov-Dec       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.